PET
0.02
185.7%
SFG
0.002
-33.3%
QFE
0.085
44.1%
CDR
0.016
-20%
IVX
0.105
32.9%
GLL
0.008
-20%
ATH
0.01
25%
OEL
0.004
-20%
EPXDA
0.2
21.2%
OVT
0.004
-20%
APC
0.012
20%
RLG
0.004
-20%
GRE
0.084
18.3%
CZN
0.15
-16.7%
BDG
0.088
17.3%
TEM
0.005
-16.7%
PDI
0.732
17.1%
VRC
0.005
-16.7%
AJX
0.007
16.7%
ZEU
0.01
-16.7%
AT1
0.031
14.8%
ALM
0.006
-14.3%
ATV
0.024
14.3%
GES
0.006
-14.3%
ENV
0.008
14.3%
BOC
0.725
-13.7%
TMS
0.008
14.3%
T3D
0.044
-13.7%
BRK
0.525
14.1%
RB6
0.1
-13%
MVL
0.017
13.3%
ASP
0.007
-12.5%
4DX
1.865
12.7%
NES
0.007
-12.5%
AA2
0.315
12.5%
MYG
2.45
-11.9%
ARV
0.009
12.5%
NOR
0.015
-11.8%
LKE
0.088
11.4%
A11
0.2
-11.1%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EZZ Life Science (ASX: EZZ): Targets US expansion followingFDA product approvals

Australian genomic life science company EZZ Life Science (ASX: EZZ) has won approval from the United States (US) Food and Drug Administration (FDA) for nine of its products in the food category, presenting a significant US expansion opportunity for EZZ. | ASX announcement: https://announcements.asx.com.au/asxpdf/20240625/pdf/064x2fh3lh72px.pdf